ProteoWise Inc.
Biotechnology company · New Haven, Connecticut, United States
ProteoWise Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $251,944 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $2.3 million sold in a notice filed in 2024.
ProteoWise at a glance
What does ProteoWise do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $251,944 in total (2020). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $2.3 million sold (2024).
Frequently asked questions about ProteoWise
Where is ProteoWise headquartered?
ProteoWise Inc. is headquartered in New Haven, Connecticut, United States.
What does ProteoWise do?
ProteoWise Inc. is a biotechnology company.
When was ProteoWise founded?
The earliest incorporation on record for ProteoWise Inc. is in 2018, according to public company registers.
Similar companies
- Allyx Therapeutics, Inc.New Haven, Connecticut, United States
- Invivyd, Inc.New Haven, Connecticut, United States
- ReNetX Bio, Inc.New Haven, Connecticut, United States
- AtlasXomics Inc.New Haven, Connecticut, United States
- Vion Pharmaceuticals IncNew Haven, Connecticut, United States
- Oui Therapeutics IncNew Haven, Connecticut, United States
- Modifi Biosciences, Inc.New Haven, Connecticut, United States
- Cybrexa, Inc.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences